| Tag | Content |
|---|
EnhancerAtlas ID | HS139-10675 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr11:111418320-111420340 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EN2 | MA0642.1 | chr11:111420010-111420020 | CCCAATTAGC | + | 6.02 | | EWSR1-FLI1 | MA0149.1 | chr11:111418518-111418536 | ACTTCCTGCCATCTTTCC | - | 6.18 | | SPI1 | MA0080.4 | chr11:111418985-111418999 | AAAAACGGGAAGTT | + | 6.29 | | STAT1 | MA0137.3 | chr11:111419293-111419304 | TTTCCAGGAAA | + | 6.62 | | Sox3 | MA0514.1 | chr11:111420273-111420283 | AAAACAAAGG | - | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_52162 | chr11:111419311-111421243 | Skeletal_Muscle_Myoblast | | SE_63980 | chr11:111419297-111421355 | HSMM |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH11I111548 | chr11 | 111419449 | 111421061 |
|
Enhancer Sequence | CATGTTAACC TGCTTTAGCA AAGACACCAC ATATGGCACA GGCAGCCACA ATCAGGCTTC 60
CACTTGGTTG AGTTTGTGCT ACTCTATTAT CACCTTCAGG ATCTGCCTGG TGTTTTCAGG 120
AGTCAAGACT AGTGAATTAA CTAGAGATGC AATGGGGAAC ACCACTCTTG GATTCTTTGG 180
GTCTTTAAGG GTGACACTAC TTCCTGCCAT CTTTCCCTGG ATAAGATATT GTTGTTGATT 240
TATTATCATG GCAGGGGTGG GGAGGAGTGC AGTTTCAAAG GCTTCCCCAC TTGACATTCT 300
CCACCGTGAT AGCTCTTGCC CCACAGGTAA GTAGACCAAG AGACGACGCA GCTCAACCTG 360
CCCATCATAG GCCAAGGAAC CAATGTGGAA CTGTACCAAC TAAAAATATG TCTGTTCAAT 420
TCATATATTT GGGGACTGGG GAATGATGAC TGGCTGGGTG CCACTATGAG CTGATCCTGG 480
GCCAGACCTC TACTTAATAC CTGTCCCCAG TATGCTCCCA TTCTAATGGG TAGCTTTGAT 540
GACACTTTAA GTCTGAGTAT TAATGTCAAC TTGCACCCTG TGTCCAACAG CCCTTGTAAT 600
ATTTGGATAT TCCCTCTTCC CCGCTGTATG GTTACTGGAG GAAATAGCCA TGGATCCCTT 660
TAGGGAAAAA CGGGAAGTTA TTACCATGTG CACCTGCCGT GGTGTTGCAA GGTCCTTCTT 720
ACTGGAAACC TGGCCTCTCT ATCAGTGAGT TCTGGGTCTG AAAATTGGCT CAAGTACAGA 780
AATTATACAC CAGACATAAT ATTCAACCTA TAAGACAAAA TAATGTAAAG CCATAAGGCC 840
AGTGGGGAGG GGAACAAGGC AAGTCAGGGT AGGAGGCCCA ACAGGGCTGG AATCTGGACT 900
GGAGATAACT AATGAGGTGC CCCCAGCTGT CCAGTCATAG TATCCAAGGA GTGTTTATTG 960
TAAGCTAAGC TATTTTCCAG GAAATTCAAT CCAGTGAGTG CAGCAAAGGA TGTTCCTTTT 1020
AGTAGACAAC AATACAGGAC TTAAGCAGAG CCTTACTGTG GCGCTACAGG GAGAGCTGTC 1080
TCTTGCTGTC TCTTTCCTGA AGAGGGCTCT GACAAGAGCT AAGCAGAGCA GCATTGCCTG 1140
CTCTGAGCAT CAGAGCAAGA TCTGAGCCCT AGAAGGAAAC AGCTCAGGCA ACTAACCAGG 1200
GAGGTTACAA AGCCCAGCCC TGAGTCAGCA CATGGGGTGG GTACTCACAG ATGTAAACGC 1260
TCCATAAGAT CCAAGGCTTT AACCTGGCAC CCACATATCC AACTGGGTGG CAGCACCATT 1320
TAGTTTCAAG TGCCACTGGA TAGTAGTGTA AGGTTGCTAA TGCACCCCTC TAGGGGGCTA 1380
GGGAGACAAA GACAAGACAT CTGGAGGTAG AGGCTGAGGG GCTCATCAGC CTTATCAAGT 1440
GGAAACAACT TAAAAACTGA AAAAGACCAA ATGGTCCTCC TGCTTTTGTC CCCACCCTTT 1500
CACCTGTTTT GACAGCCTCT ATGTTTGGAA TGTCTTGCTC ATGTGCTTGA ATTTCTTATC 1560
TACTTCCCAG GGCTGAAAAG GCAGTTGGTG GCTGTTGAAA ATCATGGAGA GATGAGAGCA 1620
GGGCAAGCTC TGGATGAGAT AAGCCATGTC TCTTCTCAGT GCATCTGAGA TCTAAAAAAA 1680
GACAAACAAA CCCAATTAGC AAAAAGCAAG AAAGAAATAA GATCGTCCAG ACTAGCCCTG 1740
CTGGCTGCTT TTTCTCATAA TTACTTTACA GACATCATAT GGTGGCATGT TCCTCCCTGC 1800
AAAGAGATTG TGGCAAATGT CAGATGATTG ATTGTGATGT CCATATGAGA ATGCGTGTGG 1860
TTCTGCTTAC TGGCAGTACT TCAATTCCTA CCTCTCTCTG TATCATGTTC TGAGGCAGAA 1920
TCTTATGTTT ATGGCTCAGT GAGACTTGAC GGGAAAACAA AGGCTTTGAA GTCTCAGGGG 1980
ATCCTTCTCC AGTTGCCTCT ACTGCTGATC CCTTCCCTAC 2020
|
